main image

Why Choose Nanosyn?

Nanosyn is a drug discovery services company with a proven record of identifying and advancing hits to clinical candidates.  Nanosyn specializes in medicinal, synthetic, analytical, and process chemistry and biological screening and profiling of compounds. With the soaring cost and length of today's drug development process, Nanosyn's products and services have become critical components of proprietary drug development platforms at pharmaceutical companies worldwide.

  • QUALITY:  The quality and integrity of the science and technical  processes, on which we partner with clients, is paramount.
  • COMMUNICATION: Efficient, effective communication is fundamental to the success off all clients' projects.
  • TIME IS OF THE ESSENCE: On-time delivery of results and materials is second only to ensuring their quality.
  • SERVICE PARTNERSHIP: Clients are in full control of all IP.
  • INNOVATION: It is fundamental to our clients’ success that we continuously add the most recent science and technology to our knowledge base and lab instrumentation.

Company Overview

Nanosyn is a privately held chemistry-based enterprise founded in 1998 by a group of industry experts specializing in the design, synthesis, and analysis of small molecule organic compounds for the pharmaceutical industry. Our client base consists of pharmaceutical, biotech, and academic institutions. Nanosyn has a well established track record, encompassing well over a hundred business relationships throughout the United States and the rest of the world. 

The original intent of Nanosyn, Inc. creators was solely resting upon concepts of "miniaturized chemistry" - catering to the true needs of the biotech research sectors for cost-efficient and environmentally-conscientious, nanoscaled compounds. Naturally, with the rapid growth of the company's market share and diversity, Nanosyn evolved into a Chemistry on Demand service provider.

Today, we are proud to offer versatile services that are specifically tailored to each client's individual needs. Full utilization of our intellectual resources, proprietary technology, state-of-the-art automation and robotics enables us to provide innovative solutions to advance the process of drug discovery.

In 2003 and 2004, two of Nanosyn's patents were issued based upon its state-of-the-art core technology and processes. Currently Nanosyn utilizes this technology to generate revenue and to continually develop leading technology based upon automation, robotics, and computational techniques. 

Nanosyn's headquarters in Santa Clara, California focuses on comprehensive drug discovery and chemistry services. Additionally, we also operate Phase 1 to commercial cGMP kilo labs in Santa Rosa, CA.

Nanosyn on Facebook Nanosyn on Twitter Nanosyn on LinkedIn